Eleni Frangou
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 10, 2026
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial.Gareth Hughes, Elena Frangou, Henry Bern
|Aug 02, 2025
Brain Imaging and Whole Blood Targeted Transcriptomic Analyses to Characterize Cerebral Infarctions in Children With Tuberculous Meningitis.Julie Huynh, Pieter M Pretorius, Wajanat Jan
|Feb 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.Bhavna Oza, Tim Eisen, Eleni Frangou
|Oct 14, 2020
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.Tim Eisen, Eleni Frangou, Bhavna Oza
|Dec 29, 2017
Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit.Eleni Frangou, Jane Holmes, Sharon Love
Pageof 1
Frequent Collaborators
3 joint publications
Grant D Stewart
2 joint publications
Rick Kaplan
2 joint publications
Mahesh K B Parmar
2 joint publications
Steven Joniau
2 joint publications
Ian D Davis
2 joint publications
Joaquim Bellmunt
2 joint publications
Angela Meade
2 joint publications
Gregers G Hermann
2 joint publications
James Larkin
2 joint publications
Tim Eisen
